Home
Research
Submit Article
News
Sectors
Advertise
Premium
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
Two Week FREE Trial
About Us
About Us
Editorial Staff
Terms and Conditions
Privacy Policy
Contact Us
iStock Rating
B
Details...
Enter Symbol
Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX)
Sector: Medical
Current Price :
$5.39
52 Week Low
$3.33
52 Week High
$11.02
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
133M
Market Cap:
$0.69B
Avg Volume:
838451
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Opinion and Analysis
Idenix Pharmaceuticals (IDIX) Initiated As 'Buy' By Deutsche Bank; PT $7
Nov 28, 2012 01:49 PM |
IDIX
Idenix (IDIX) Upgraded To 'Hold' By Brean Murray Given Sharp Decline In Valuation
Aug 17, 2012 11:18 AM |
IDIX
Stocks End In Green As Merkel, Housing Data, Cisco (CSCO) Weigh
Aug 16, 2012 04:16 PM |
A
,
CSCO
,
CSTR
,
DLTR
,
IDIX
,
NTAP
More Articles on IDIX..
Press Releases
Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference
Jun 11, 2013 04:05 PM |
IDIX
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
Jun 10, 2013 08:02 AM |
IDIX
Idenix Pharmaceuticals Announces Samatasvir (IDX719) Poster Presentations at the Asian Pacific Association for the Study of the Liver (APASL) Conference
Jun 06, 2013 08:01 AM |
IDIX
More Press Releases on IDIX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
IDIX
Compare to S&P
YTD
6.80 %
-6.36 %
4 Weeks
24.22 %
27.33 %
12 Weeks
12.61 %
7.77 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-35.29 %
EPS Growth in Last Year:
-330.00 %
Sales Growth in Last Quarter:
160.55 %
Sales Growth in Last Quarter:
-97.61 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##